In conclusion, we described the therapeutic effects of Ori on LPS-induced ALI using a mouse model, as evidenced by the reduction of inflammatory cell infiltration, decrease of inflammatory cytokines and inhibition of NF-κB activation, which suggests that Ori could be a novel therapeutic option for ALI or other inflammatory diseases. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.